Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?

Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?